Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial (Q44125123)
Jump to navigation
Jump to search
scientific article published on August 1, 1992
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial |
scientific article published on August 1, 1992 |
Statements
1 reference
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial (English)
E. S. Surrey
1 August 1992
1 reference
1 reference
75
1 reference
2
1 reference
558-563
1 reference
Identifiers
1 reference
1 reference